Blood test boosts Alzheimer's diagnosis accuracy to 94.5%, clinical study shows
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein called p-tau217, affect both the clinical diagnosis of Alzheimer's and neurologists' confidence in their diagnosis. After following 200 consecutive new patients aged 50 and older who presented with cognitive symptoms, they found that a simple blood test measuring p-tau217 significantly improved diagnostic accuracy in routine clinical practice. When relying solely on standard clinical evaluation, doctors correctly diagnosed
p-tau217 tests significantly increased diagnostic confidence in patients with cognitive symptoms. Credit: Pexels A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein called p-tau217, affect both the clinical diagnosis of Alzheimer's and neurologists' confidence in their diagnosis. After following 200 consecutive new patients aged 50 and older who presented with cognitive symptoms, they found that a simple blood test measuring p-tau217…
saved by
related reading
- 'Breakthrough' blood test can find dementia risk before symptoms startnypost.com
- FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease | FDAfda.gov
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- Eye test can detect early Alzheimer'stherecord.com
- Brain Imaging in Differential Diagnosis of Dementiapracticalneurology.com
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
- It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough | Jonathan Schott | The Guardiantheguardian.com
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- APOE2 is associated with longevity independent of Alzheimer’s diseasencbi.nlm.nih.gov
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores: A Texas Alzheimer's Research Consortium Study - PMCncbi.nlm.nih.gov
- Accuracy of the Early Diagnosis of Parkinson’s Diseasepmc.ncbi.nlm.nih.gov
- Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand? - PubMedpubmed.ncbi.nlm.nih.gov